Nisa Investment Advisors
ALXO icon

Nisa Investment Advisors’s ALX Oncology ALXO Stock Holding History

Nisa Investment Advisors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22K Hold
1,106
– – ﹤0.01% 2599
2025
Q4 		$1.25K Hold
1,106
– – ﹤0.01% 2685
2025
Q3 		$2.02K Sell
1,106
-365
-25% -$316 ﹤0.01% 2618
2025
Q2 		$611 Buy
1,471
+771
+110% +$389 ﹤0.01% 2837
2025
Q1 		$436 Sell
700
-2
-0.3% -$2 ﹤0.01% 2824
2024
Q4 		$1.17K Buy
702
+42
+6% +$65 ﹤0.01% 2641
2024
Q3 		$1.2K Buy
660
+54
+9% +$201 ﹤0.01% 2531
2024
Q2 		$3.65K Buy
606
+204
+51% +$2.51K ﹤0.01% 2303
2024
Q1 		$4.48K Buy
402
+10
+3% +$140 ﹤0.01% 2132
2023
Q4 		$5.84K Hold
392
– – ﹤0.01% 2112
2023
Q3 		$1.88K Buy
392
+10
+3% +$54 ﹤0.01% 2346
2023
Q2 		$2.87K Hold
382
– – ﹤0.01% 2350
2023
Q1 		$2K Buy
382
+32
+9% +$242 ﹤0.01% 2309
2022
Q4 		$4K Hold
350
– – ﹤0.01% 2305
2022
Q3 		$4K Hold
350
– – ﹤0.01% 2312
2022
Q2 		$3K Sell
350
-600
-63% -$6.53K ﹤0.01% 2307
2022
Q1 		$16K Sell
950
-2,050
-68% -$35K ﹤0.01% 2105
2021
Q4 		$48K Buy
+3,000
New +$129K ﹤0.01% 1743

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Nisa Investment Advisors's ALXO Position: Q1 2026 in Review

Nisa Investment Advisors held its ALX Oncology (ALXO) position steady in Q1 2026 at 1,106 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Nisa Investment Advisors first reported a position in ALXO in Q4 2021 and has held it in 18 quarters since. The position peaked at $48K in Q4 2021. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Nisa Investment Advisors held 1,106 shares of ALX Oncology worth $2.22K as of Q1 2026.
  • Nisa Investment Advisors left its ALX Oncology share count unchanged in Q1 2026.
  • ALX Oncology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2599 holding.
  • Nisa Investment Advisors first reported a position in ALX Oncology in Q4 2021 and has held it in 18 quarters since.
  • Nisa Investment Advisors's ALX Oncology position peaked at $48K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.